Today, investors in Petros Pharmaceuticals and PTPI stock are cheering a telemedicine agreement, sending shares of this company skyrocketing. More
Articles
Moderna’s Outlook Is Directly Tied to the Eventual Receding of Covid-19
With Covid-19 receding and a one-dimensional product pipeline, MRNA stock is a one-trick-pony without any long-term prospects. More
BIRD Stock IPO: 7 Things to Know as Allbirds Starts Trading Today
Today, one of the big talking points in the market is the BIRD stock IPO, which saw a massive increase of 100% in early trading. More
Ripple Promises Growth for Investors — But at Their Own Risk
With Ripple, anyone can send money around without hassle in a secure manner, making it one of the most sought-after digital tokens around. More
Bitcoin Price Predictions: Why JPMorgan Thinks BTC is Worth $35K… or $146K
JPMorgan Chase, through its unclear Bitcoin price predictions, shows that BTC's future is uncertain. Here's why, and what else to know. More
Ethereum Price Predictions: How High Can ETH Climb After Hitting New Record?
Today, Ethereum's rise to a new all-time high has many investors considering what the Ethereum price predictions are for this coin. More
Ride Teladoc’s Recovery to Big Financial Gains
After a solid third-quarter earnings report, virtual healthcare company Teladoc's stock looks to be on the mend following a bruising decline over the last six months. TDOC stock has climbed 10% higher since the telemedicine company delivered better-than-expected financial results on October 27. That rise brings the share price up a total of 19% over the past month to now change hands at around $150 per share. More
